<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about CVS</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Thu, 23 May 2013 06:25:28 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=CVS" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/stock-market-news-for-may-21-2013-market-news-cm247559">
      <guid isPermaLink="false">247559</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Ioo6xsoF5E/stock-market-news-for-may-21-2013-market-news-cm247559</link>
      <category>Investing</category>
      <category>US Markets</category>
      <title>Stock Market News for May 21, 2013 - Market News</title>
      <description>Investors grew cautious on Monday owing to fears over a correction and a Federal Reserve official's comments on monetary stimulus. Encouraging developments on corporate acquisitions could not&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/4Ioo6xsoF5E" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 21 May 2013 18:30:15 Z</pubDate>
      <a10:updated>2013-05-21T15:29:56Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ACT</nasdaq:tickers>
      <nasdaq:tickers>CL</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>XLE</nasdaq:tickers>
      <nasdaq:tickers>XLP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/stock-market-news-for-may-21-2013-market-news-cm247559</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/green-light-for-wag-and-abc-deal-analyst-blog-cm247310">
      <guid isPermaLink="false">247310</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AYSXVbs_T28/green-light-for-wag-and-abc-deal-analyst-blog-cm247310</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Green Light for WAG and ABC Deal - Analyst Blog</title>
      <description>The largest retail pharmacy chain in the U.S.,  Walgreen Co.  (  WAG  ) and Alliance Boots continue to make steady progress to boost their global presence in the prescription drug purchasing&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/AYSXVbs_T28" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 20 May 2013 23:04:21 Z</pubDate>
      <a10:updated>2013-05-20T20:05:24Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABC</nasdaq:tickers>
      <nasdaq:tickers>CAH</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/green-light-for-wag-and-abc-deal-analyst-blog-cm247310</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/6-healthy-products-that-arent-cm247304">
      <guid isPermaLink="false">247304</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zjEA_EJaq5Y/6-healthy-products-that-arent-cm247304</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>6 Healthy Products That Aren't</title>
      <description>There's a sucker born every minute: a phrase that's as true today as it was when coined over a century and a half ago about P. T. Barnum and his suggestible sideshow customers. Though we may no&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/zjEA_EJaq5Y" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 20 May 2013 22:30:00 Z</pubDate>
      <a10:updated>2013-05-21T16:32:56Z</a10:updated>
      <author>Diane Bullock</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>SKX</nasdaq:tickers>
      <nasdaq:tickers>TGT</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
      <nasdaq:tickers>WMT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/6-healthy-products-that-arent-cm247304</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/walgreens-reaches-new-52week-high-analyst-blog-cm246726">
      <guid isPermaLink="false">246726</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YSun2hHT99w/walgreens-reaches-new-52week-high-analyst-blog-cm246726</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Walgreens Reaches New 52-Week High - Analyst Blog</title>
      <description>Shares of  Walgreen Co.  (  WAG  ) touched a new 52-week high of $50.50 on Wednesday, May 15, 2013 following strong annual results of Alliance Boots GmbH. Walgreens has a 45% equity ownership&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/YSun2hHT99w" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 16 May 2013 22:30:07 Z</pubDate>
      <a10:updated>2013-05-16T20:34:04Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABC</nasdaq:tickers>
      <nasdaq:tickers>CAH</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>PBM</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/walgreens-reaches-new-52week-high-analyst-blog-cm246726</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/walgreen-co-wag-exdividend-date-scheduled-for-may-17-2013-cm246586">
      <guid isPermaLink="false">246586</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jxQYLampRRQ/walgreen-co-wag-exdividend-date-scheduled-for-may-17-2013-cm246586</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Walgreen Co. (WAG) Ex-Dividend Date Scheduled for May 17, 2013</title>
      <description>Walgreen Co. (  WAG  ) will begin trading ex-dividend on May 17, 2013. A cash dividend payment of $0.275 per share is scheduled to be paid on June 12, 2013. Shareholders who purchased WAG stock&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/jxQYLampRRQ" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 16 May 2013 17:00:04 Z</pubDate>
      <a10:updated>2013-05-16T13:17:46Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>FMK</nasdaq:tickers>
      <nasdaq:tickers>FXG</nasdaq:tickers>
      <nasdaq:tickers>PMR</nasdaq:tickers>
      <nasdaq:tickers>PSL</nasdaq:tickers>
      <nasdaq:tickers>RHS</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/walgreen-co-wag-exdividend-date-scheduled-for-may-17-2013-cm246586</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/walgreenscvs-extend-pharmacy-deal-analyst-blog-cm246138">
      <guid isPermaLink="false">246138</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gkNCSsb-yzY/walgreenscvs-extend-pharmacy-deal-analyst-blog-cm246138</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Walgreens-CVS Extend Pharmacy Deal - Analyst Blog</title>
      <description>In the most recent strategic maneuver to boost its pharmacy network,  Walgreens  (  WAG  ), the largest retail pharmacy chain in the U.S., extended its agreement as a network pharmacy provider&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/gkNCSsb-yzY" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 15 May 2013 02:07:22 Z</pubDate>
      <a10:updated>2013-05-14T23:07:12Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABC</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>PBM</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/walgreenscvs-extend-pharmacy-deal-analyst-blog-cm246138</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/us-physical-therapy-inc-usph-exdividend-date-scheduled-for-may-15-2013-cm245843">
      <guid isPermaLink="false">245843</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ot68Wf_OUs/us-physical-therapy-inc-usph-exdividend-date-scheduled-for-may-15-2013-cm245843</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>U.S. Physical Therapy, Inc. (USPH) Ex-Dividend Date Scheduled for May 15, 2013</title>
      <description>U.S. Physical Therapy, Inc. (  USPH  ) will begin trading ex-dividend on May 15, 2013. A cash dividend payment of $0.1 per share is scheduled to be paid on June 07, 2013. Shareholders who&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/3ot68Wf_OUs" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 14 May 2013 17:00:03 Z</pubDate>
      <a10:updated>2013-05-14T13:34:11Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>USPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/us-physical-therapy-inc-usph-exdividend-date-scheduled-for-may-15-2013-cm245843</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/pernix-reports-loss-in-1q-analyst-blog-cm245692">
      <guid isPermaLink="false">245692</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HWaRf0BfWMY/pernix-reports-loss-in-1q-analyst-blog-cm245692</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Pernix Reports Loss in 1Q  - Analyst Blog</title>
      <description>Pernix Therapeutics Holdings, Inc's  (  PTX  ) first quarter 2013 adjusted loss (including stock-based compensation expense) of 6 cents per share, compared unfavorably to the Zacks Consensus&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/HWaRf0BfWMY" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 23:16:15 Z</pubDate>
      <a10:updated>2013-05-13T20:08:25Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>PTX</nasdaq:tickers>
      <nasdaq:tickers>SNTS</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/pernix-reports-loss-in-1q-analyst-blog-cm245692</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/why-walgreen-is-a-good-buy-for-patient-investors-cm245632">
      <guid isPermaLink="false">245632</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eV2UIRHU89s/why-walgreen-is-a-good-buy-for-patient-investors-cm245632</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Why Walgreen Is a Good Buy for Patient Investors</title>
      <description>Walgreen  (  WAG  ) operates the largest chain of drugstores in the US, with over 8,000 freestanding locations throughout all 50 states, the District of Columbia, and Puerto Rico.    An&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/eV2UIRHU89s" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 20:05:00 Z</pubDate>
      <a10:updated>2013-05-13T17:15:30Z</a10:updated>
      <author>MoneyShow.com</author>
      <nasdaq:tickers>ABC</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/why-walgreen-is-a-good-buy-for-patient-investors-cm245632</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bios-misses-earnings-mark-but-rev-tops-analyst-blog-cm244899">
      <guid isPermaLink="false">244899</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_94fTv9X-Rs/bios-misses-earnings-mark-but-rev-tops-analyst-blog-cm244899</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>BIOS Misses Earnings Mark But Rev Tops - Analyst Blog</title>
      <description>In the first quarter of 2013,  BioScrip Inc.  (   BIOS  ) posted  adjusted earnings per share (EPS) of a penny, better than the  year-ago adjusted loss of 2 cents. Nonetheless, the result&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_94fTv9X-Rs" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 May 2013 18:20:01 Z</pubDate>
      <a10:updated>2013-05-09T14:27:24Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BIOS</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>GNC</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bios-misses-earnings-mark-but-rev-tops-analyst-blog-cm244899</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mckesson-earnings-down-in-4q-analyst-blog-cm244619">
      <guid isPermaLink="false">244619</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vzXcsIi-8uQ/mckesson-earnings-down-in-4q-analyst-blog-cm244619</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>McKesson Earnings Down in 4Q - Analyst Blog</title>
      <description>McKesson Earnings Down in 4Q     McKesson Corporation's (  MCK  ) fourth quarter of fiscal 2013 (ended Mar 31, 2013) adjusted earnings (including non-cash impairment charges and severance and&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/vzXcsIi-8uQ" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 08 May 2013 19:06:01 Z</pubDate>
      <a10:updated>2013-05-08T16:23:42Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>MCK</nasdaq:tickers>
      <nasdaq:tickers>PMC</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mckesson-earnings-down-in-4q-analyst-blog-cm244619</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/another-month-of-plump-sales-for-wag-analyst-blog-cm243955">
      <guid isPermaLink="false">243955</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/--NyWK9PREQ/another-month-of-plump-sales-for-wag-analyst-blog-cm243955</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Another Month of Plump Sales for WAG - Analyst Blog</title>
      <description>Drug retailer  Walgreen Co.  (  WAG  ) recently disclosed exhaustive results for the month of Apr 2013. The company posted another month of sales improvement after March as April sales inched&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/--NyWK9PREQ" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 06 May 2013 23:20:01 Z</pubDate>
      <a10:updated>2013-05-06T20:26:56Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/another-month-of-plump-sales-for-wag-analyst-blog-cm243955</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/drugstore-chains-write-prescription-for-growth-cm243565">
      <guid isPermaLink="false">243565</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VWHCnjSh9nU/drugstore-chains-write-prescription-for-growth-cm243565</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>Drugstore Chains Write Prescription For Growth</title>
      <description>They call it an earnings surprise. But the fact that the three top drugstore chains beat analyst consensus earnings forecasts for the first quarter, with room to spare, shocked no one.  The&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/VWHCnjSh9nU" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 23:12:00 Z</pubDate>
      <a10:updated>2013-05-03T20:29:31Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>GNC</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
      <nasdaq:tickers>WFM</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/drugstore-chains-write-prescription-for-growth-cm243565</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/rite-aids-april-comps-fall-analyst-blog-cm243464">
      <guid isPermaLink="false">243464</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nUf7jtQu3mA/rite-aids-april-comps-fall-analyst-blog-cm243464</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Rite Aid's April Comps Fall - Analyst Blog</title>
      <description>Drugstore chain retailer,  Rite Aid Corporation  's (  RAD  ) same-store sales (comps) for the 4 weeks ended Apr 27, 2013 slid 4.0%. The fall was due to a decline in pharmacy as well as&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/nUf7jtQu3mA" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 19:32:06 Z</pubDate>
      <a10:updated>2013-05-03T17:14:49Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
      <nasdaq:tickers>WMT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/rite-aids-april-comps-fall-analyst-blog-cm243464</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/etf-update-is-the-retail-sector-ready-for-earnings-cm243243">
      <guid isPermaLink="false">243243</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qW4ywYNvXoA/etf-update-is-the-retail-sector-ready-for-earnings-cm243243</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>ETF Update: Is the Retail Sector Ready for Earnings?</title>
      <description>As the rapid onslaught of quarterly reports begins to subside, one group of stocks takes center stage: retailers. Heading into the proverbial back nine of earnings season, the  SPDR S&amp;amp;P&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qW4ywYNvXoA" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 May 2013 22:36:00 Z</pubDate>
      <a10:updated>2013-05-02T20:27:55Z</a10:updated>
      <author>Schaeffer&amp;#39;s Investment Research</author>
      <nasdaq:tickers>CBOE</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>KMX</nasdaq:tickers>
      <nasdaq:tickers>LOW</nasdaq:tickers>
      <nasdaq:tickers>M</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/etf-update-is-the-retail-sector-ready-for-earnings-cm243243</feedburner:origLink></item>
  </channel>
</rss>
